MedPath

Effect of topical furosemide on nasal polype relaps

Not Applicable
Conditions
asal polyposis.
nasal polyp, unspecified
Registration Number
IRCT201403143186N5
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
82
Inclusion Criteria

patients referred to Besat hospital clinic with chronic rhinosinusitis (according to AAO-HNS) who have not responded to medical therapy and age with 18-60 years old.
Exclusion criteria: pregnancy; history of hypertension? cardiac diseases? hypokalemia; history of tinnitus; history of sensory neural hearring loss and hypersensitivity to furosemide.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
asal and paranasal sinus polyposis. Timepoint: Before intervention,1 month, 3 months, 6 months after intervention. Method of measurement: SNOT-22 questionnaire, PNS CT scan scoring, VAS, Meltzer grading.
Secondary Outcome Measures
NameTimeMethod
Burning sensation. Timepoint: 1 month, 3 months, 6 months after intervention. Method of measurement: Questionnaire.;Epistaxis. Timepoint: 1 month, 3 months, 6 months after intervention. Method of measurement: Questionnaire and physical examinatin.;Hypersensitivity. Timepoint: 1 month, 3 months, 6 months after intervention. Method of measurement: Questionnaire and physical examinatin.
© Copyright 2025. All Rights Reserved by MedPath